A Study of Atezolizumab in Advanced Solid Tumors
Clinical trial NCT02458638 · COMPLETED
Trial details
- NCT number
- NCT02458638
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-16
- Primary completion
- 2018-04-04
- Enrollment
- 474
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.